Search Saint Luke's

AARP talked to Dr. James O'Keefe about the benefits of omega fatty acids and how much you should be consuming.

The use of prescription drugs for ADHD has significantly increased in the past few decades. James O'Keefe, MD studies the link between these medications and cardiovascular events.

The groundbreaking STEP-HFpEF study, led by Mikhail Kosiborod, MD, vice president of research at Saint Luke's Health System, has been named one of the top advances by the American Heart Association.

Dr. Suzanne Arnold weighs in on new findings that may help explain how anger contributes to the risk of having a heart attack.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

On the day after Andrew Widman returned home from Saint Luke’s Hospital of Kansas City with his new heart, his wife, Vicki, drove him to the DMV. There he ordered a personalized license plate that read simply “745.” It’s a number that’s particularly close to his heart.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

Jim Mitchell faced a dilemma — miss rehearsal for a play he was producing during crunch time, or risk having a heart attack. Read his story.

A growing body of evidence correlates shorter running sessions to significant health benefits, especially those regarding longevity and mental health.

A team of cardiologists has used cardiac imaging technology to confirm that cardiovascular disease was a significant issue thousands of years ago.